Clinical Trial Documentation Management System - FluxAI Healthcare Demo

Clinical Trial Documentation Dashboard

AI Assistant Insights

I've analyzed your trial documentation and found these insights:

Protocol Amendment Required

Inclusion criteria discrepancy in sections 3.2 and 5.4 may require formal amendment.

Regulatory Submission Ready

All documentation for FDA quarterly submission is complete and verified.

Documentation Pattern

Similar adverse event reporting patterns found across three study sites - may indicate training need.

Documentation Health

Updated 5 min ago by AI
Overall Health 86%
Protocol Documents
98%
Case Report Forms
92%
Regulatory Submissions
76%
Safety Reports
64%

Document Processing

All systems operational
Processing Now

Phase II Protocol Amendment 3

OCR Extraction

68% Complete

Recently Processed

Safety Report Q1-2025
2 hours ago
Informed Consent v3.2
Yesterday
Study Site Report
2 days ago

Active Clinical Trials

FLUX-ONK-2025-003

Oncology - Phase II

Active
156 documents
Updated 2 days ago
3 AI insights

FLUX-CARDIO-2024-001

Cardiovascular - Phase III

Pending Review
284 documents
Updated today
7 AI insights

FLUX-NEURO-2024-007

Neurology - Phase I

Active
94 documents
Updated yesterday
5 AI insights

AI Recommendations

Generated based on your activity

Generate Trend Analysis

The system detected similar adverse event patterns across three trial sites that might provide valuable insights.

Review Protocol Inconsistency

AI detected potential inconsistency between inclusion criteria definitions in Section 3.2 and Section 5.4 of FLUX-ONK-2025-003 protocol.

Prepare FDA Submission

All documentation for quarterly FDA submission is complete. AI can assist in preparing the final package.

Recent Activity

AI Assistant 10 min ago

Processed and analyzed Phase II Protocol Amendment 3 for FLUX-ONK-2025-003.

Dr. Emily Johnson 1 hour ago

Uploaded 3 new safety reports for FLUX-CARDIO-2024-001 trial.

AI Assistant 2 hours ago

Generated comparative analysis of adverse events across all active trial sites.

Dr. Mark Wilson Yesterday

Requested AI-generated protocol deviation analysis for FLUX-NEURO-2024-007.

Upcoming Deadlines

AI monitored
2d

FDA Safety Report Submission

April 22, 2025

FLUX-CARDIO-2024-001 High Priority
5d

IRB Protocol Amendment Submission

April 25, 2025

FLUX-ONK-2025-003 Medium Priority
12d

Quarterly Data Monitoring Report

May 2, 2025

All Active Trials Regular Priority